Review
[ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION]
[Article in
Swedish]
- PMID: 14276462
Item in Clipboard
Review
[ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION]
[Article in
Swedish]
Sven Lakartidn.
.
No abstract available
Similar articles
-
[ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. II. DRUG-THERAPEUTIC INQUIRY ON CEREBROVASCULAR SIDE-EFFECTS, WITH MEDICOLEGAL ASPECTS OF THE USE OF MAO INHIBITORS].Sven Lakartidn. 1964 Dec 2;61:3794-807. Sven Lakartidn. 1964. PMID: 14276463 Swedish. No abstract available.
-
[EXPERIMENTAL AND CLINICAL CONSIDERATIONS ON A NEW ANTIDEPRESSIVE DRUG NOT AN ENCEPHALIC MONOAMINE OXIDASE INHIBITOR DERIVED FROM IPRONIAZIDE (TIBICOR)].G Psichiatr Neuropatol. 1964;92:1021-41. G Psichiatr Neuropatol. 1964. PMID: 14304145 Italian. No abstract available.
-
TREATMENT OF DEPRESSION.Lancet. 1965 May 1;1(7392):923-5. Lancet. 1965. PMID: 14275707 No abstract available.
-
Reversible monoamine oxidase-A inhibitors in resistant major depression.Clin Neuropharmacol. 1993;16 Suppl 2:S69-76. Clin Neuropharmacol. 1993. PMID: 8313400 Review.
-
THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME.Can Med Assoc J. 1965 Apr 10;92(15):821-8. Can Med Assoc J. 1965. PMID: 14272501 Free PMC article. Review.